Quantifying patient health for precision rehabilitation in modern medicine: a presentation by Spoke 2 at the RAISE Village
On October 31, at the RAISE Village, Jacopo Zenzeri, CEO of ReWing, delivered a talk titled “Quantifying Patient Health for Precision Rehabilitation in Modern Medicine”, where he showcased the AGLAIA platform, developed under Spoke 2.
In contemporary rehabilitation medicine, personalized treatment is increasingly vital, highlighting the need for advanced tools that enable precise clinical assessments of patient health. Traditional assessments lack the accuracy required to fully customize treatment, making objective and reproducible measurements essential to monitor patient capabilities and enhance rehabilitation program effectiveness.
The AGLAIA platform (Platform for Global Assessment and Personalized Rehabilitation based on Robotics and Artificial Intelligence), developed in collaboration with technology partners ReWing, ETA Bioengineering, and Pragma Engineering, aims to revolutionize patient health assessment by integrating cutting-edge technology. The platform combines robotic tools, wearable sensors, and artificial intelligence to deliver quantitative and precise evaluations of each patient’s sensory, motor, and cognitive abilities.
Beyond providing accurate assessments, AGLAIA generates personalized recommendations for rehabilitation plans, adapting therapy to meet the unique needs of each patient. This innovative technology integration allows for ongoing progress monitoring and dynamic treatment adjustments, enhancing clinical outcomes and fostering a patient-centered approach to rehabilitation.
“Being part of the RAISE ecosystem is essential for us. We were fortunate to win one of the cascade calls offered by RAISE, but the true value lies in being part of a community rich in scientific and clinical stakeholders. Engaging with this network enables us to grow and improve as an organization. Additionally, the support for our project brings innovation not only to rehabilitation but also within our company,” commented Jacopo Zenzeri at the close of his presentation.
